Please enable JavaScript.
Coggle requires JavaScript to display documents.
Systemic sclerosis (CREST Syndrome (Calcinosis (Calcium deposits in…
Systemic sclerosis
CREST Syndrome
-
Calcinosis
Calcium deposits in fingers and over bony prominences
May break through skin and drain white material
May cause infection and ulceration
Not related to the amount of calcium in food or calcium supplement
Raynaud’s phenomenon
- episodic vasoconstriction of the small arteries and arterioles of fingers and toes
- Stimulus: cold exposure, Vibration, emotional stress
- Phases of syndrome:
-White – pallor -> secondary to vasospasm
-Blue – cyanosis -> produced by deoxygenated blood
-Red - blushing -> reactive hyperemia
Sclerodactyly
- Flexion contractures of fingers limiting full extension
- edema of the fingers and hands
Telangiectasia
- due to dilatation of the postcapillary venules located in the papillary and superficial reticular dermis
- clinical markers of widespread aberrant microvascular disease (underlying pulmonary arterial hypertension (PAH ) or gastric antral vascular ectasia GAVE).
Treatment
- goals of therapy are to halt:
Vascular damage
Immune cell activation
Fibrogenesis
- Drugs to prevent vascular damage
calcium channel blockers , ACEI, prostaglandins, endothelin- receptors inhibitors, phosphodiesterase inhibitors
- Drugs that suppress autoimmunity and infection
Cyclophosphamide, Methotrexate, Azathiopryne, Stem cell transplant, mycophenolate mofetil
- Drugs that suppress fibrosis
D-penicylamina, IFN, relaxin, plasma exchange
- Treatment of scleroderma -controversy with glucocorticoids:
Indicated in SSc induced inflammatory myositis, pericarditis, edematous phase of skin involvement and early alveolitis of lung
High dose (30mg/d) is associated with scleroderma renal crisis
-
Diagnosis
- blood:
anti-topoisomerase 1/anti-Scl-70: specific but not sensitive for diffuse systemic sclerosis
anti-centromere: favours diagnosis of CREST (limited systemic sclerosis)
- Imaging studies:CXR for brosis, echo for pulmonary HTN
- PFT
- (ACR)/ (EULAR) Criteria for Scleroderma*
Scleroderma Forms
Localised
- no involvement of internal organs
- Mostly children and young adults
- Morphea, Linear, En coupe de sabre, Combinations.
-
findings
- Skin involvment:
Raynaud’s phenomenon
edema of the fingers and hands (sclerodactyly)
skin thickening
- Arthralgia and muscle weakness
-
-
Raynaud’s Phenomenon DDx
- COLD HAND
Cryoglobulins/Cryofibrinogens
Obstruction/Occupational
Lupus erythematosus, other connective tissue disease
Diabetes mellitus/Drugs
Hematologic problems (polycythemia, leukemia, etc.)
Arterial problems (atherosclerosis)/Anorexia nervosa
Neurologic problems (vascular tone)
Disease of unknown origin (idiopathic)
Prognosis
- Poor prognosis:
DSSc
Old age
Males
Rapidly progressing skin lesions
- chronic multisystem disorder
- unknown etiology
- characterized by the overproduction and accumulation of collagen with thickening of the skin, structural and functional abnormalities of the visceral organs, including the GI tract, lung, heart and kidneys.
- common in female.
- age 40-50 yr
- associated with HLA-DR1
- associated with environmental exposure (silica, resins)
- disease consisting of abnormalities in:
-the vascular system (Endothelial cell injury, Vasoconstriction, Vascular occlusion, Tissue hypoxia)
-the immune system ( T cell activation, Macrophage activation, Autoantibodies, Cytokines)
-the fibrosis